About

About Pelago Bioscience At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage. Unlike traditional methods, CETSA allows us to assess drug-target interactions in physiologically relevant, unmodified cellular environments—so you can be confident that what you see in cells, you will also see in patients. Our services rest on four pillars: · Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks. · Fast & Early Confidence: We deliver actionable insights in just 4-10 weeks, eliminating unnecessary complexities so you can make decisions faster. · Insights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs. · Extended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals. With Pelago, you gain more than just data; you gain a trusted partner in your discovery journey.